Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients.
Frontiers in immunology
View this publicationFrontiers in immunology
View this publicationAmerican journal of hematology
View this publicationBMC complementary medicine and therapies
View this publicationInternational journal of molecular sciences
View this publicationPLoS neglected tropical diseases
View this publicationEuropean heart journal
View this publicationFrontiers in genetics
View this publicationNature reviews. Drug discovery
View this publicationFrontiers in cellular and infection microbiology
View this publicationInternational journal of molecular sciences
View this publication